Search results
Results from the WOW.Com Content Network
The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally. [6] [7] Merck operates in Europe, Africa, Asia, Oceania and the Americas.
Merck Consumer Health is a fully integrated division of the German chemical and pharmaceutical company Merck KGaA. It offers a wide range of over-the-counter products to consumers in more than 100 countries and belongs to the global top 20 of the most successful companies in the OTC industry. [ 2 ]
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical ...
South Africa's government said it was not planning to buy Merck's COVID-19 treatment pill molnupiravir on Thursday for cost reasons, despite the drug gaining approval from the country's health ...
In the quest to find great investments, most investors focus on earnings to gauge a company's financial strength. This is a good start, but earnings can be misleading and incomplete. To get a ...
(Reuters) -A Bangladeshi drugmaker will soon begin selling the world's first generic version of Merck's COVID-19 pill, molnupiravir, which has been touted as a potential game-changer in the fight ...
McKesson was under contract by Pfizer not to sell to any correctional facility that authorized and carried out capital punishment. [27] [28] In November 2018, the company announced it would relocate its headquarters from San Francisco to Irving, Texas, effective April 1, 2019. [29] [30] Also in April 2019, Brian Tyler took over as CEO of the ...
2014 – Merck KGaA announced that it would purchase Sigma-Aldrich for approx. $17 billion (€13.1 billion). [16] [17] November 3, 2014 – Sigma-Aldrich filed a definitive proxy statement with the U.S. Securities and Exchange Commission to hold a special investors meeting regarding approval for the sale to Merck KGaA. [18]